Status:
UNKNOWN
Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer
Lead Sponsor:
Beijing Friendship Hospital
Conditions:
Invasive Breast Cancer
Cavitation
Eligibility:
All Genders
18+ years
Brief Summary
Blood perfusion insufficiency and hypoxia are the main causes of drug resistance to chemotherapy in breast cancer. Increasing blood perfusion can improve drug delivery. The cavitation effect of ultras...
Detailed Description
patients with IBC were selected from the breast surgery department of our hospital. To induce an enhanced perfusion effect, IBC tumors were treated with SonoVue® microbubbles (MBs) stimulated by ultra...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Invasive Breast Cancer
- patients scheduled to undergo surgical resection
- maximum lesion diameter \< 4 cm
- age over 18 years
Exclusion
- patients with allergies to SonoVue®
- patients with severe cardiopulmonary insufficiency,
- patients who had already received neoadjuvant chemotherapy
- pregnant women
- individuals with mental illness
- Patients who refused to participate in the study
Key Trial Info
Start Date :
September 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 6 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06158217
Start Date
September 29 2022
End Date
May 6 2025
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Friendship Hospital, Capital Medical University
Beijing, China, 100050